(19)
(11) EP 4 200 274 A2

(12)

(88) Date of publication A3:
07.04.2022

(43) Date of publication:
28.06.2023 Bulletin 2023/26

(21) Application number: 21859286.3

(22) Date of filing: 14.09.2021
(51) International Patent Classification (IPC): 
C07C 59/01(2006.01)
A61P 3/02(2006.01)
 A61K 31/19(2006.01)
C12P 7/42(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/19; A61K 9/0095; A61K 9/06; A61K 45/06; A61K 47/183; A61K 47/12
(86) International application number:
PCT/US2021/050302
(87) International publication number:
WO 2022/040644 (24.02.2022 Gazette 2022/08)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 18.08.2020 US 202016996509
24.03.2021 US 202117210646

(71) Applicant: Axcess Global Sciences, LLC
Salt Lake City, UT 84106 (US)

(72) Inventor:
  • MILLET, Gary
    Salt Lake City, Utah 84121 (US)

(74) Representative: Schwarz & Partner Patentanwälte GmbH 
Patentanwälte Wipplingerstraße 30
1010 Wien
1010 Wien (AT)

   


(54) BETA-HYDROXYBUTYRIC ACID COMPOSITIONS AND METHODS FOR ORAL DELIVERY OF KETONE BODIES